Literature DB >> 31156835

Level of concordance between two risk-assessment models for predicting venous thromboembolism in medical patients at admission.

Ana De Lorenzo-Pinto1, Raquel García-Sánchez1, Esther Durán-García1, Ana Castuera-Gil2, Cristina Pascual-Izquierdo3, Belén Marzal-Alfaro1, Paula Arrabal-Durán1, Ana Herranz-Alonso1, Juan A Andueza-Lillo2, María Sanjurjo-Sáez1.   

Abstract

OBJECTIVES: To evaluate the level of concordance between the 2007 PRETEMED guidelines and the 2012 American College of Chest Physicians (ACCP) guidelines in medical patients at admission.
METHODS: A cross-sectional, observational and descriptive study was designed and included all adult medical patients admitted from an emergency department. Firstly, patients classified as low-moderate risk and high risk according to PRETEMED were compared to those classified by ACCP as low and high risk. Secondly, the same analysis was performed but this time low and moderate-high risk patients according to PRETEMED were compared to ACCP low and high risk patients. The level of concordance was calculated using the kappa concordance index. The study was approved by the Ethics Committee for Clinical Research of the hospital.
RESULTS: The analysis was performed with 207 patients; 53.1% were male and the median age was 75.3 years (minimum 18, maximum 100 years old). The most common diagnosis at admission was related to a respiratory disease (37.2%). The level of concordance was 0.59 (95% CI 0.48 to 0.70) when moderate risk patients were grouped with low-risk patients and 0.53 (95% CI 0.42 to 0.65) when moderate risk patients were grouped with high-risk patients.
CONCLUSIONS: The level of concordance between both guides is moderate. It would be helpful to confirm whether the level of agreement improves when the patient's condition stabilises after several days of hospitalisation.

Entities:  

Keywords:  ACCIDENT & EMERGENCY MEDICINE; CLINICAL PHARMACY

Year:  2015        PMID: 31156835      PMCID: PMC6451527          DOI: 10.1136/ejhpharm-2015-000694

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  13 in total

1.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis.

Authors:  Jacques Rizkallah; S F Paul Man; Don D Sin
Journal:  Chest       Date:  2008-09-23       Impact factor: 9.410

Review 3.  Risk factors for venous thromboembolism.

Authors:  Samuel Z Goldhaber
Journal:  J Am Coll Cardiol       Date:  2010-06-29       Impact factor: 24.094

4.  About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes.

Authors:  Alberto Martínez-Castelao; José L Górriz; Eva Sola; Carlos Morillas; Ana Jover; Francisco Coronel; Juan Navarro-González; Fernando De Álvaro
Journal:  Nefrologia       Date:  2012-07-17       Impact factor: 2.033

5.  [Assessment of venous thromboembolism risk in hospitalized medical patients. Concordance between PRETEMED guide and the recommendations of the viii conference of the American College of Chest Physicians].

Authors:  Patricia Gallardo Jiménez; Ricardo Guijarro Merino; Verónica Vallejo Herrera; David Sánchez Morales; Aurora Villalobos Sánchez; Juan Ignacio Perelló González-Moreno; Ricardo Gómez-Huelgas
Journal:  Med Clin (Barc)       Date:  2011-10-26       Impact factor: 1.725

6.  Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative.

Authors:  Leslie Raffini; Tara Trimarchi; Johanna Beliveau; Daniela Davis
Journal:  Pediatrics       Date:  2011-04-04       Impact factor: 7.124

Review 7.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve.

Authors:  Hikmat Abdel-Razeq
Journal:  Ann Thorac Med       Date:  2010-10       Impact factor: 2.219

9.  [Venous thromboprophylaxis in medical patients: an application review].

Authors:  Mariana Nassif Kerbauy; Fabio Ynoe de Moraes; Lucila Nassif Kerbauy; Lucieni de Oliveira Conterno; Silene El-Fakhouri
Journal:  Rev Assoc Med Bras (1992)       Date:  2013-05-13       Impact factor: 1.209

10.  Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.

Authors:  Alexander T Cohen; Victor F Tapson; Jean-Francois Bergmann; Samuel Z Goldhaber; Ajay K Kakkar; Bruno Deslandes; Wei Huang; Maksim Zayaruzny; Leigh Emery; Frederick A Anderson
Journal:  Lancet       Date:  2008-02-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.